STERIS Q2 FY2027 Revenue Rose 9% to $1.59B, Adjusted EPS $2.94; Full-Year Guidance Raised
· The NYC Memo
STERIS plc (STE) reported fiscal second quarter 2027 results on November 4, 2026, with total revenue of $1,588.6 million, up 9% year-over-year from $1,460.3 million, and constant currency organic revenue growth of 8%. Adjusted diluted EPS rose 19% to $2.94 from $2.47 in the prior-year period, while GAAP diluted EPS increased to $2.19 from $1.94.
The company raised its fiscal 2027 adjusted EPS outlook to $11.35–$11.55 from $11.10–$11.30, citing solid underlying performance and approximately $0.18 per share benefit from tariff refunds received year-to-date, while also disclosing a new restructuring plan with anticipated total charges of approximately $45 million expected to generate roughly $9 million in annualized savings.